ABVC vs WELL · rev $509.6K vs P/E 100, rev $10.84B
ABVC Biopharma Inc (ABVC) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ABVC currently screens at market cap $35.9M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ABVC and WELL stock pages for the full models.
Not investment advice.